BioXcel Therapeutics (BTAIQ) Cost of Revenue (2022 - 2026)
BioXcel Therapeutics (BTAIQ) reported Cost of Revenue of $22,000 for Q2 2026, down 79.4% from $107,000 a year earlier and down 92.2% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Cost of Revenue (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioXcel Therapeutics' Cost of Revenue came in at $348,000, down 83.6% year-over-year; for FY2025, it was $164,000, down 92.3% from FY2024.
- Cost of Revenue has a three-year compound annual growth rate of 101.7% (FY2022 to FY2025).
- By year, Cost of Revenue came in at $2.14 million in FY2024 (+70.1%), $1.26 million in FY2023 and $20,000 in FY2022.
- Five-year quarterly Cost of Revenue spans a low of $9,000 in Q4 2022 and a high of $1.17 million in Q3 2024.
- Year over year, Cost of Revenue gained in three of the last seven quarters, with an average decline of 19.9%.
- The high point for year-over-year Cost of Revenue in five years was Q1 2024 (growth of 788.9%); the low point was Q3 2025 (a decline of 99.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $283,000 (Q1 2026), $32,000 (Q4 2025) and $11,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | BioXcel Therapeutics | 626,099.99 | -93.99 Mn | 160,000.00 | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 283,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 832,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 11,000.00 |
API Access
BioXcel Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();